(Total Views: 281)
Posted On: 03/02/2022 9:55:48 AM
Post# of 231

$GNPX News Article - Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA(TM) Immunogene Therapy in Combination with Tagrisso to Treat Non-Small Cell Lung Cancer https://marketwirenews.com/news-releases/genp...99471.html
My Twitter: WhyteStocks